IONIS PHARMACEUTICALS INC
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
IONS$28.19-9.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net loss | $(453,897) | $(366,286) | $(269,722) |
| Unrealized gains (losses) on investments, net of tax | 2,107 | 24,484 | (24,395) |
| Currency translation adjustment | (273) | 351 | (417) |
| Comprehensive loss | $(452,063) | $(341,451) | $(294,534) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.